V&C Biotec continues as an active member of the International Society for Cell & Gene Therapy (ISCT)

We are pleased to announce that, as of July 1, V&C Biotec has renewed its membership in the International Society for Cell & Gene Therapy (ISCT), a global network of more than 2,400 professionals dedicated to the development and application of cell and gene therapies (CGT), including some of the most influential thought leaders in the field today. Since 1992, ISCT has worked to advance these therapies through a focus on evidence-based translational value, bringing together experts across scientific, regulatory and commercial domains to drive consensus and action worldwide. As members of this global society, we commit to upholding the vision of translating cell and gene therapies into safe and effective treatments that improve patients' lives, while meeting the highest ethical standards.